In February 2013, Celgene Corporation was awarded the prestigious EURORDIS (The European Organisation for Rare Diseases) Company Award for excellence in the field of rare diseases.
Along with the achievements of other companies, the award recognizes Celgene’s medical commitment as well as its success story with several approved drugs for rare diseases and a number of other promising, innovative preparations.